Ecopetrol
EC
Adobe
ADBE
Lennar Corp
LEN
Petroleo Brasileiro SA Petrobras
PBR
Vale SA
VALE
US Stock MarketDetailed Quotes
ANEB Anebulo Pharmaceuticals
- 1.550
- -0.070-4.32%
Trading Dec 26 11:23 ET
63.68MMarket Cap-5.17P/E (TTM)
1.674High1.490Low9.26KVolume1.490Open1.620Pre Close14.29KTurnover0.05%Turnover RatioLossP/E (Static)41.08MShares3.30052wk High33.70P/B29.55MFloat Cap0.80052wk Low--Dividend TTM19.06MShs Float9.330Historical High--Div YieldTTM11.35%Amplitude0.800Historical Low1.543Avg Price1Lot Size
Anebulo Pharmaceuticals News
Anebulo Pharmaceuticals | 8-K: Current report
Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cunningham, Richard Anthony
Anebulo Pharmaceuticals | 10-Q: Q1 2025 Earnings Report
Anebulo Pharmaceuticals | 8-K: Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent Updates
Anebulo Pharmaceuticals | 8-K: Current report
Anebulo Pharmaceuticals | 10-K: FY2024 Annual Report
Anebulo Pharmaceuticals | 8-K: Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Updates
Anebulo Pharmaceuticals | 8-K: Current report
Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Aryeh Jason
Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SHAH BIMAL R.
Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director English Aron R.
Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lawler Joseph F.
Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Kupchyk Areta
Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Calloway Nathaniel
Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lin Kenneth
Anebulo Pharmaceuticals | 8-K: Current report
Anebulo Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
Anebulo Pharmaceuticals | 8-K: Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Recent Updates
Anebulo Pharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Cundy Kenneth C
Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cundy Kenneth C
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
